{"schemaVersion":"peptidescanner-clinical-trials-history-object/v1","objectId":"clinical-trials-history:NCT02969590","recordId":"NCT02969590","peptideSlug":"leuprolide","publishedAt":"2026-08-23","sourceObservedAt":"2026-08-23T23:32:33.000Z","sourceObservationSha256":"6ae8058d20bbb511d9250d19ac0bd3475945bb56f0057fdb437648218b72606e","urls":{"human":"https://peptidescanner.com/stories/clinicaltrials-gov-nct02969590-leuprolide/","json":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct02969590.json","markdown":"https://peptidescanner.com/clinical-trials-history/v1/trials/nct02969590.md"},"reportingBoundary":"ClinicalTrials.gov lists this public record-history version and identifies its submitted date and the source modules marked as changed. PeptideScanner does not infer what changed inside a module, why it changed, whether the change is material, whether the study is trustworthy, or whether an intervention is safe or effective.","versions":[{"changedModules":[],"historyVersion":1,"lastUpdateSubmitQcDate":"2016-11-17","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"RECRUITING","peptideSlug":"leuprolide","submittedDate":"2016-11-17","publishedAt":"2026-08-23","recordId":"NCT02969590","recordSha256":"cefcda731f1d33c1ae9cbfb6e8d18e34057634ec4d9d9792c4506368944b63eb","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02969590?a=1&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Contacts/Locations","Study Status"],"historyVersion":2,"lastUpdateSubmitQcDate":"2017-10-25","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"ACTIVE_NOT_RECRUITING","peptideSlug":"leuprolide","submittedDate":"2017-10-25","publishedAt":"2026-08-23","recordId":"NCT02969590","recordSha256":"87b5a0b75cf983e34910e1bbbbc5967704cf408773f4dea18d399871ee8c263c","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02969590?a=2&tab=history","studyType":"INTERVENTIONAL"},{"changedModules":["Adverse Events","Arms and Interventions","Baseline Characteristics","Document Section","More Information","Outcome Measures","Outcome Measures (Results)","Participant Flow","Study Design","Study Status"],"historyVersion":4,"lastUpdateSubmitQcDate":"2019-10-16","observedAt":"2026-08-23T23:32:33.000Z","overallStatus":"COMPLETED","peptideSlug":"leuprolide","submittedDate":"2019-10-16","publishedAt":"2026-08-23","recordId":"NCT02969590","recordSha256":"050133d16796d5bea072a3cec2ae17a2a1f1e3d4d054b3b4440c8f87f2f9f6aa","schemaVersion":"tier-a-clinicaltrials-gov-history-public-record/v1","sourceUrl":"https://clinicaltrials.gov/study/NCT02969590?a=4&tab=history","studyType":"INTERVENTIONAL"}],"integrity":{"algorithm":"sha256","contentSha256":"ad2181b2fe5caa055bb92427ba4488318b7234781737cb0862819f81d1e11794"}}